Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-02-23 @ 3:01 PM
Study NCT ID:
NCT02700568
Status:
COMPLETED
Last Update Posted:
2019-10-22
First Post:
2016-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Sponsor:
Kidney Cancer Research Bureau
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-18
First Submit QC Date:
None
Study First Post Date:
2016-03-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-18
Last Update Post Date:
2019-10-22
Last Update Post Date Type:
ACTUAL